Loop Capital analyst Andrew Wolf lowered his price target on Core-Mark to $31 from $38 after the company cut its Q4 guidance on Friday in anticipation of the ICR Conference. Wolf says he now views Core-Mark management with "far greater circumspection", but remains confident that the company "remains very well positioned to profitably gain market share". Wolf keeps his Buy rating on Core-Mark, adding that its valuation is below the median of its peer Specialty Food Distributors group.

07/05/18

LOOP

07/05/18NO CHANGETarget $32LOOPBuy

Core-Mark price target raised to $32 at Loop Capital on more constructive view

Loop Capital analyst Andrew Wolf raised his price target on Core-Mark to $32 from $30 and kept his Buy rating, citing a more constructive outlook from its management and "stabilizing cigarette consumption". Wolf notes that the company is gaining market share among independent convenience retailers, while its free cash generation plans are expected to produce a more deleveraged balance sheet. The analyst adds that this will give Core-Mark more financial flexibility with opportunity for M&A in 2019.

HIGHER: Newmont Mining (NEM), up 2% after Bloomberg reports Barrick Gold (GOLD) has studied a bid for the company as it looks for ways to boost production... Achieve Life Sciences (ACHV), up 62% after announcing final data from their Phase I/II multi-dose, pharmacokinetic and pharmacodynamics clinical study of cytisinicline in smokers... Intel (INTC), up 3% after Morgan Stanley analyst Joseph Moore upgraded shares to Overweight from Equal Weight, citing his belief that shares "can rerate higher" given that the company has put "a more financially oriented CEO" in charge with the appointment of Robert Swan. UP AFTER EARNINGS: Wayfair (W), up 16%... Trade Desk (TTD), up 18%. DOWN AFTER EARNINGS: Kraft Heinz (KHC), down 25%... Stamps.com (STMP), down 52%... AutoNation (AN), down 4%. ALSO LOWER: Fitbit (FIT), down 1% after Wedbush analyst Michael Pachter downgraded the stock to Neutral from Outperform, as shares have reached his $6.50 price target with no new available information on the MedTech opportunity... Lam Research (LRCX), down 2% after Morgan Stanley analyst Joseph Moore downgraded shares to Equal Weight from Overweight, stating that if he is right in his view that memory margins will continue to fade through the second half of this year than wafer fab equipment spending may continue to weaken into 2020.